Abstract:Objective To investigate the mechanisms of emodin in the treatment of autoimmune thyroiditis (AT) in mice. Methods The 60 mice were randomly divided into normal group, model group and experimental group, with 20 mice in each group. The experimental group was intragastrically given 75 mg/kg emodin once a day for 8 weeks; the control group and the model group were given the same dose of normal saline once a day for 8 weeks. The levels of thyroglobulin antibody (TGAb) and thyroid peroxidase antibody (TPOAb) were measured by enzyme-linked immunosorbent assay; the degree of lymphocyte infiltration in the thyroid gland was observed; and the changes of T-lymphocyte subsets in peripheral blood were measured by flow cytometry. Results The serum TGAb and TPOAb levels were significantly different among the three groups, and those in experimental group were lower than those in model group (P < 0.05). The degree of lymphocyte infiltration was distinct among the groups, and that in the experimental group was lower compared to that in model group (P < 0.05). Besides, the CD3+CD4+ and CD3+CD8+ cell counts were different among the groups, and those in the experimental group were lower in comparison to those in model group (P < 0.05). Conclusion Emodin can reduce the serum TGAb and TPOAb, ameliorate the degree of lymphocyte infiltration and regulate the immune function in AT mice.